The Health Dose newsletter from Holland & Knight is a comprehensive weekly update on legislative and regulatory developments in Washington, D.C. that impact the health sector. The aim of this newsletter is to keep stakeholders informed and up to date on the latest happenings in the industry.
This week’s edition covers a wide range of topics, including the FAA Reauthorization, House passage of the Congressional Budget Office Data Sharing Act, and the Senate Committee on Finance’s release of a discussion draft on drug shortages. Additionally, the House Ways and Means Committee is set to mark up legislation to extend telehealth waivers, FDA officials will be appearing before the E&C Subcommittee, and there will be hearings on administrative and regulatory burdens in healthcare in both the House and Senate.
Hearings were also held last week on cyberattacks, Medicaid and LTSS, maternal mortality, workforce diversity, Medicare and Social Security Trustees released their annual reports, and the HHS, DOL, Treasury Department issued Cost Sharing FAQs. Other notable developments include HHS releasing draft guidance for the Second Cycle of Medicare Drug Price Negotiation Program; FDA releasing a Laboratory Developed Test Final Rule; finalization of a DACA Health Coverage Rule; new appointments to Medicaid CHIP Payment and Access Commission (MACPAC).
